LB Pharmaceuticals Inc. (LBRX)
NGM · Common · CUSIP 50180M108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for LBRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
50180M108
IPO
9/11/2025 · $15.00/share
Business: LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.

Company Contact

CEO
Heather Turner
CFO
Joseph M. Miller
Headquarters
One Pennsylvania Plaza, Suite 1025, New York, NY 10119
Phone
212-605-0230
Investor Relations
ir@lbpharma.us
SEC EDGAR Filings
View filings »